InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Lee Gary K.. Officer active across 1 company, notably Lyell Immunopharma, Inc.. Aggregated, 9 disclosures have been published. Split: 0 buy · 5 sells. Total volume traded: €57k. History available since 9 February 2024. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Lee Gary K. is a declarant linked to Lyell Immunopharma, Inc., where he is Chief Scientific Officer. The 8 filings recorded in the recent sample run from 2024-02-13 to 2026-08-11, with EUR 37617 of sales and EUR 0 of purchases; the modal transaction nature is sale.